C. Dugast

发表

2009 version of the Chompret criteria for Li Fraumeni syndrome.

Catherine Bonaïti-Pellié, Dominique Stoppa-Lyonnet, Stéphanie Baert-Desurmont, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies

A. Fabre, L. Faivre, H. Sobol, 2016, Annals of Hematology.

Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations

I. de Mascarel, G. MacGrogan, R. Iggo, 2010, Breast Cancer Research.

Idiopathic Gastric Acid Hypersecretion in a Patient With MUTYH-Associated Polyposis

C. Dugast, B. Meunier, M. Blayau, 2009, The American Journal of Gastroenterology.

The contribution of germline rearrangements to the spectrum of BRCA2 mutations

P. Chappuis, R. Lidereau, D. Stoppa-Lyonnet, 2006, Journal of Medical Genetics.

Mutation screening of MIR146A/B and BRCA1/2 3′-UTRs in the GENESIS study

D. Stoppa-Lyonnet, O. Sinilnikova, S. Mazoyer, 2016, European Journal of Human Genetics.

BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer

T. Frebourg, B. Clarisse, F. Joly, 2017, Familial Cancer.

EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: report of two cases and review of the literature.

J. Mosser, A. Lespagnol, C. Dugast, 2015, Lung cancer.

Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer risk

P. Laurent-Puig, J. Duffour, J. Saurin, 2015, European Journal of Human Genetics.

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

W. Chung, J. Benítez, R. Eeles, 2020, Breast Cancer Research.

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial

J. Lemonnier, P. Pujol, J. Fricker, 2011, Familial Cancer.

A survey of factors determining the utilization of autologous blood donation in hip replacement surgery.

C. Dugast, J. Bernard, 1997, European journal of anaesthesiology.

A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

F. Révillion, Chloé-Agathe Azencott, N. Sevenet, 2020, BMC Medical Research Methodology.

A.191 Quality assessment of predonated autologous blood in hip-replacement surgery

C. Dugast, J. Bernard, 1996 .

Molecular study of CEPBA in familial hematological malignancies

L. Huiart, L. Demange, L. Faivre, 2009, Familial Cancer.

Breast cancer in a male with ankylosing spondylitis treated with TNFalpha antagonists.

C. Dugast, G. Chalès, A. Perdriger, 2009, Joint, bone, spine : revue du rhumatisme.

Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma

L. Thomas, S. Richard, B. Teh, 2011, Journal of Medical Genetics.

Colorectal Adenomatous Polyposis Associated with MYH Mutations: Genotype and Phenotype Characteristics

D. Bonneau, B. Buecher, L. Siproudhis, 2007, Diseases of the colon and rectum.

Generation of multinucleated giant cells by culture of monocyte‐derived macrophages with IL‐4

C. Dugast, L. Toujas, A. Gaudin, 1997, Journal of leukocyte biology.

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes

T. Frebourg, Baptiste Brault, P. Berthet, 2014, European Journal of Human Genetics.

High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome

V. Brouste, N. Sevenet, B. Gilbert-Dussardier, 2013, Journal of Medical Genetics.

Familial hematological malignancies: ASXL1 gene investigation

L. Faivre, H. Sobol, C. Dugast, 2016, Clinical and Translational Oncology.

Molecular study of the perforin gene in familial hematological malignancies

L. Huiart, L. Demange, L. Faivre, 2011, Hereditary cancer in clinical practice.

Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene

R. Lidereau, T. Frebourg, M. Vezain, 2008, Journal of Medical Genetics.

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)

R. Lidereau, D. Stoppa-Lyonnet, P. Pujol, 2012, Breast Cancer Research.

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1/2 carrier cohort (GENEPSO).

R. Lidereau, D. Stoppa-Lyonnet, P. Pujol, 2018 .

Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests

D. Khayat, R. Lidereau, M. Picot, 2013, Breast Cancer Research and Treatment.

Hereditary Ovarian Cancers and Rare Malignant Ovarian Tumors

C. Dugast, A. Lortholary, A. Yvard, 2014 .

GENESIS: a French national resource to study the missing heritability of breast cancer

D. Stoppa-Lyonnet, O. Sinilnikova, S. Mazoyer, 2016, BMC Cancer.

Mutational analysis of apoptotic genes in familial aggregation of hematological malignancies.

L. Faivre, H. Sobol, C. Dugast, 2021, Bulletin du cancer.

Gastric carcinoma in Sotos syndrome (cerebral gigantism).

L. Pasquier, C. Dugast, S. Odent, 1999, Annales de genetique.

Winged helix hepatocyte nuclear factor 3 and POU-domain protein brn-2/N-oct-3 bind overlapping sites on the neuronal promoter of human aromatic L-amino acid decarboxylase gene.

M. Weber, C. Dugast, J. Raynal, 1998, Brain research. Molecular brain research.

GATA2 gene analysis in several forms of hematological malignancies including familial aggregations

L. Faivre, H. Sobol, C. Dugast, 2017, Annals of Hematology.

Gastric involvement in juvenile polyposis associated with germline SMAD4 mutations: an entity characterized by a mixed hypertrophic and polypoid gastropathy.

D. Heresbach, C. Dugast, J. Bretagne, 2008, Gastroenterologie clinique et biologique.

NF-Y binding is required for transactivation of neuronal aromatic L-amino acid decarboxylase gene promoter by the POU-domain protein Brn-2.

M. Weber, C. Dugast, 2001, Brain research. Molecular brain research.

Familial hematological malignancies: new IDH2 mutation

A. Paci, V. Penard-Lacronique, L. Faivre, 2016, Annals of Hematology.

Molecular basis of the Li–Fraumeni syndrome: an update from the French LFS families

C. Bonaïti‐pellié, D. Stoppa-Lyonnet, A. Chompret, 2008, Journal of Medical Genetics.

ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.

L. Faivre, H. Sobol, C. Dugast, 2017, Bulletin du cancer.

Five year letrozole versus placebo in BRCA1/2 germline mutations carriers: Final results of LIBER, a double-blind randomized phase III breast cancer prevention trial.

J. Lemonnier, P. Pujol, J. Fricker, 2020 .

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial

J. Lemonnier, P. Pujol, J. Fricker, 2012, Familial Cancer.